(-)-anisomycin multiple interactions ISO RGD:733441 6480464 Dicumarol inhibits the reaction [Anisomycin results in increased activity of MAPK10 protein] CTD PMID:10531305 (-)-anisomycin increases activity ISO RGD:733441 6480464 Anisomycin results in increased activity of MAPK10 protein CTD PMID:10531305 (R)-noradrenaline multiple interactions ISO RGD:11285 6480464 MAPK10 protein affects the reaction [MAPK9 protein affects the susceptibility to Norepinephrine] CTD PMID:16949803 1,2-dibromoethane increases expression ISO RGD:11285 6480464 Ethylene Dibromide results in increased expression of MAPK10 mRNA CTD PMID:15612046 1,2-dichloroethane increases expression ISO RGD:11285 6480464 ethylene dichloride results in increased expression of MAPK10 mRNA CTD PMID:28960355 17alpha-ethynylestradiol affects expression ISO RGD:11285 6480464 Ethinyl Estradiol affects the expression of MAPK10 mRNA CTD PMID:17555576 17beta-hydroxy-5alpha-androstan-3-one multiple interactions ISO RGD:733441 6480464 APOE gene polymorphism affects the reaction [Dihydrotestosterone affects the phosphorylation of MAPK10 protein] CTD PMID:17395708 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2-ethoxyethanol increases expression EXP 6480464 2-ethoxyethanol results in increased expression of MAPK10 mRNA CTD PMID:19643169 2-methoxyethanol increases expression EXP 6480464 methyl cellosolve results in increased expression of MAPK10 mRNA CTD PMID:19643169 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:11285 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of MAPK10 mRNA CTD PMID:26251327 4,4'-sulfonyldiphenol decreases expression ISO RGD:11285 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of MAPK10 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol affects methylation ISO RGD:733441 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of MAPK10 gene CTD PMID:31601247 8-Br-cAMP decreases expression ISO RGD:733441 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MAPK10 mRNA CTD PMID:22079614 acetohydrazide decreases expression ISO RGD:11285 6480464 acetylhydrazine results in decreased expression of MAPK10 mRNA CTD PMID:15282401 aflatoxin B1 decreases methylation ISO RGD:733441 6480464 Aflatoxin B1 results in decreased methylation of MAPK10 gene CTD PMID:27153756 all-trans-retinoic acid decreases expression ISO RGD:733441 6480464 Tretinoin results in decreased expression of MAPK10 mRNA CTD PMID:21934132 all-trans-retinoic acid decreases expression ISO RGD:11285 6480464 Tretinoin results in decreased expression of MAPK10 mRNA CTD PMID:22498432 aristolochic acid A decreases expression ISO RGD:733441 6480464 aristolochic acid I results in decreased expression of MAPK10 mRNA CTD PMID:33212167 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of MAPK10 gene CTD PMID:28931070 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of MAPK10 mRNA CTD PMID:21839799 benzo[a]pyrene increases methylation ISO RGD:733441 6480464 Benzo(a)pyrene results in increased methylation of MAPK10 promoter CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:11285 6480464 Benzo(a)pyrene results in decreased methylation of MAPK10 intron CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:733441 6480464 Benzo(a)pyrene affects the methylation of MAPK10 5' UTR CTD PMID:27901495 benzo[b]fluoranthene decreases expression ISO RGD:11285 6480464 benzo(b)fluoranthene results in decreased expression of MAPK10 mRNA CTD PMID:26377693 bis(2-chloroethyl) sulfide increases expression ISO RGD:11285 6480464 Mustard Gas results in increased expression of MAPK10 mRNA CTD PMID:15674843 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:11285 6480464 Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of MAPK10 mRNA] CTD PMID:33484791 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:733441 6480464 Diethylhexyl Phthalate results in decreased expression of MAPK10 mRNA CTD PMID:31163220 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of MAPK10 mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO RGD:733441 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of MAPK10 gene CTD PMID:31601247 bisphenol A increases methylation ISO RGD:733441 6480464 bisphenol A results in increased methylation of MAPK10 gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:11285 6480464 bisphenol A results in decreased expression of MAPK10 mRNA CTD PMID:30951980 , PMID:32156529 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of MAPK10 gene CTD PMID:28505145 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Genistein] results in increased methylation of MAPK10 gene CTD PMID:28505145 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MAPK10 mRNA CTD PMID:30816183 , PMID:32528016 bisphenol F decreases expression ISO RGD:11285 6480464 bisphenol F results in decreased expression of MAPK10 mRNA CTD PMID:30951980 bortezomib multiple interactions ISO RGD:733441 6480464 [[Bortezomib co-treated with Butyrates] results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of and results in increased activity of MAPK10 protein more ... CTD PMID:15173093 butanal decreases expression ISO RGD:733441 6480464 butyraldehyde results in decreased expression of MAPK10 mRNA CTD PMID:26079696 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of MAPK10 promoter CTD PMID:22457795 cadmium dichloride decreases expression ISO RGD:733441 6480464 Cadmium Chloride results in decreased expression of MAPK10 mRNA CTD PMID:32512071 cadmium dichloride increases response to substance ISO RGD:11285 6480464 MAPK10 protein results in increased susceptibility to Cadmium Chloride CTD PMID:28163110 cadmium dichloride increases phosphorylation EXP 6480464 Cadmium Chloride results in increased phosphorylation of MAPK10 protein CTD PMID:27389774 cadmium dichloride multiple interactions EXP 6480464 Quercetin inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK10 protein] CTD PMID:27389774 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of MAPK10 mRNA CTD PMID:33453195 carmustine decreases expression ISO RGD:733441 6480464 Carmustine results in decreased expression of MAPK10 mRNA CTD PMID:15980968 CGP 52608 multiple interactions ISO RGD:733441 6480464 CGP 52608 promotes the reaction [RORA protein binds to MAPK10 gene] CTD PMID:28238834 chlordecone increases expression ISO RGD:11285 6480464 Chlordecone results in increased expression of MAPK10 mRNA CTD PMID:29980752 chromium(6+) multiple interactions ISO RGD:11285 6480464 [Arsenates co-treated with chromium hexavalent ion] results in increased expression of MAPK10 protein, [Arsenates co-treated with chromium hexavalent ion] results in increased phosphorylation of MAPK10 protein CTD PMID:19895865 chromium(6+) increases phosphorylation ISO RGD:11285 6480464 chromium hexavalent ion results in increased phosphorylation of MAPK10 protein CTD PMID:19895865 chromium(6+) increases expression ISO RGD:11285 6480464 chromium hexavalent ion results in increased expression of MAPK10 protein CTD PMID:19895865 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of MAPK10 mRNA CTD PMID:23558232 cobalt dichloride decreases expression ISO RGD:733441 6480464 cobaltous chloride results in decreased expression of MAPK10 mRNA CTD PMID:17553155 cocaine decreases expression ISO RGD:733441 6480464 Cocaine results in decreased expression of MAPK10 mRNA CTD PMID:12629581 curcumin multiple interactions EXP 6480464 Curcumin analog inhibits the reaction [Rotenone results in increased phosphorylation of MAPK10 protein] more ... CTD PMID:24952339 more ... cypermethrin increases expression ISO RGD:11285 6480464 cypermethrin results in increased expression of MAPK10 mRNA CTD PMID:29020013 D-glucitol multiple interactions ISO RGD:733441 6480464 Dicumarol inhibits the reaction [Sorbitol results in increased activity of MAPK10 protein] CTD PMID:10531305 D-glucitol increases activity ISO RGD:733441 6480464 Sorbitol results in increased activity of MAPK10 protein CTD PMID:10531305 dextran sulfate multiple interactions ISO RGD:11285 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MAPK10 mRNA CTD PMID:29950665 dichloroacetic acid increases expression ISO RGD:11285 6480464 Dichloroacetic Acid results in increased expression of MAPK10 mRNA CTD PMID:28962523 dicoumarol multiple interactions ISO RGD:733441 6480464 Dicumarol inhibits the reaction [Anisomycin results in increased activity of MAPK10 protein] more ... CTD PMID:10531305 dicoumarol decreases activity ISO RGD:733441 6480464 Dicumarol results in decreased activity of MAPK10 protein CTD PMID:10531305 dioxygen multiple interactions ISO RGD:11285 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MAPK10 mRNA CTD PMID:30529165 dorsomorphin multiple interactions ISO RGD:733441 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin multiple interactions EXP 6480464 Doxorubicin results in increased phosphorylation of and results in increased activity of MAPK10 protein, pifithrin inhibits the reaction [Doxorubicin results in increased phosphorylation of and results in increased activity of MAPK10 protein] CTD PMID:16687611 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of MAPK10 mRNA CTD PMID:32289291 doxorubicin decreases expression ISO RGD:733441 6480464 Doxorubicin results in decreased expression of MAPK10 mRNA CTD PMID:29803840 emodin increases expression ISO RGD:11285 6480464 Emodin results in increased expression of MAPK10 mRNA CTD PMID:15612046 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of MAPK10 mRNA, Endosulfan results in increased expression of MAPK10 protein CTD PMID:31464424 entinostat decreases expression ISO RGD:733441 6480464 entinostat results in decreased expression of MAPK10 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:733441 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAPK10 mRNA CTD PMID:27188386 ethanol decreases expression ISO RGD:733441 6480464 Ethanol results in decreased expression of MAPK10 mRNA CTD PMID:28986285 ethanol affects splicing ISO RGD:11285 6480464 Ethanol affects the splicing of MAPK10 mRNA CTD PMID:30319688 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of MAPK10 mRNA CTD PMID:18035473 fulvestrant multiple interactions ISO RGD:733441 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of MAPK10 gene CTD PMID:31601247 genistein increases expression ISO RGD:11285 6480464 Genistein results in increased expression of MAPK10 mRNA CTD PMID:16169203 , PMID:32186404 genistein multiple interactions EXP 6480464 [bisphenol A co-treated with Genistein] results in increased methylation of MAPK10 gene, [Genistein co-treated with Methoxychlor] results in increased expression of MAPK10 mRNA CTD PMID:21782745 , PMID:28505145 glycidol increases expression ISO RGD:11285 6480464 glycidol results in increased expression of MAPK10 mRNA CTD PMID:15612046 glyphosate increases methylation EXP 6480464 glyphosate results in increased methylation of MAPK10 gene CTD PMID:31011160 hydrogen peroxide multiple interactions EXP 6480464 AG 1879 inhibits the reaction [Hydrogen Peroxide results in increased activity of MAPK10 protein] more ... CTD PMID:15574683 , PMID:19386027 hydrogen peroxide increases response to substance ISO RGD:11285 6480464 MAPK10 results in increased susceptibility to Hydrogen Peroxide CTD PMID:20418776 hydrogen peroxide increases activity EXP 6480464 Hydrogen Peroxide results in increased activity of MAPK10 protein CTD PMID:15574683 hypochlorous acid multiple interactions ISO RGD:733441 6480464 Hypochlorous Acid results in increased phosphorylation of and results in increased activity of MAPK10 protein CTD PMID:18156441 L-serine decreases expression ISO RGD:733441 6480464 Serine results in decreased expression of MAPK10 mRNA CTD PMID:29098664 lead diacetate affects expression EXP 6480464 lead acetate affects the expression of MAPK10 CTD PMID:24293362 lipopolysaccharide increases phosphorylation ISO RGD:11285 6480464 Lipopolysaccharides results in increased phosphorylation of MAPK10 protein CTD PMID:11543732 lipopolysaccharide multiple interactions ISO RGD:733441 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MAPK10 mRNA CTD PMID:35811015 lipopolysaccharide increases expression ISO RGD:733441 6480464 Lipopolysaccharides results in increased expression of MAPK10 mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions ISO RGD:11285 6480464 Quercetin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK10 protein] CTD PMID:11543732 lithium chloride decreases expression ISO RGD:733441 6480464 Lithium Chloride results in decreased expression of MAPK10 mRNA CTD PMID:23527032 luteolin increases phosphorylation ISO RGD:733441 6480464 Luteolin results in increased phosphorylation of MAPK10 protein CTD PMID:21601631 LY294002 multiple interactions ISO RGD:733441 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Pt(O, O'-acac)(gamma-acac)(DMS) results in increased phosphorylation of MAPK10 protein] CTD PMID:21420390 melatonin increases expression ISO RGD:733441 6480464 Melatonin results in increased expression of MAPK10 protein CTD PMID:19012662 menadione decreases activity ISO RGD:733441 6480464 Vitamin K 3 results in decreased activity of MAPK10 protein CTD PMID:10531305 menadione multiple interactions EXP 6480464 Vitamin K 3 results in increased phosphorylation of and results in increased activity of MAPK10 protein CTD PMID:19386027 mercury dibromide decreases expression ISO RGD:733441 6480464 mercuric bromide results in decreased expression of MAPK10 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:733441 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAPK10 mRNA CTD PMID:27188386 metformin multiple interactions ISO RGD:733441 6480464 Metformin inhibits the reaction [IL1B protein results in increased phosphorylation of MAPK10 protein] CTD PMID:16385087 methotrexate affects expression ISO RGD:11285 6480464 Methotrexate affects the expression of MAPK10 mRNA CTD PMID:18502557 methoxychlor multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in increased expression of MAPK10 mRNA CTD PMID:21782745 methoxychlor increases expression EXP 6480464 Methoxychlor results in increased expression of MAPK10 mRNA CTD PMID:21782745 methylmercury chloride decreases expression ISO RGD:733441 6480464 methylmercuric chloride results in decreased expression of MAPK10 mRNA CTD PMID:28001369 N-acetyl-L-cysteine multiple interactions ISO RGD:733441 6480464 Acetylcysteine inhibits the reaction [[Bortezomib co-treated with Butyrates] results in increased phosphorylation of and results in increased activity of MAPK10 protein], Acetylcysteine inhibits the reaction [[Bortezomib co-treated with vorinostat] results in increased phosphorylation of and results in increased activity of MAPK10 protein] CTD PMID:15173093 N-methyl-4-phenylpyridinium increases expression ISO RGD:733441 6480464 1-Methyl-4-phenylpyridinium results in increased expression of MAPK10 mRNA CTD PMID:25234470 naringin multiple interactions ISO RGD:11285 6480464 naringin inhibits the reaction [Dietary Fats results in increased phosphorylation of MAPK10 protein] CTD PMID:22198281 nickel atom decreases expression ISO RGD:733441 6480464 Nickel results in decreased expression of MAPK10 mRNA CTD PMID:25583101 ozone multiple interactions ISO RGD:11285 6480464 [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of MAPK10 mRNA CTD PMID:34911549 p-menthan-3-ol decreases expression ISO RGD:733441 6480464 Menthol results in decreased expression of MAPK10 mRNA CTD PMID:26760959 panobinostat decreases expression ISO RGD:733441 6480464 panobinostat results in decreased expression of MAPK10 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:733441 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAPK10 mRNA CTD PMID:27188386 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of MAPK10 mRNA CTD PMID:33387578 paraquat increases response to substance ISO RGD:11285 6480464 MAPK10 results in increased susceptibility to Paraquat CTD PMID:20418776 paraquat decreases expression ISO RGD:11285 6480464 Paraquat results in decreased expression of MAPK10 mRNA CTD PMID:21371552 pentanal decreases expression ISO RGD:733441 6480464 pentanal results in decreased expression of MAPK10 mRNA CTD PMID:26079696 phenylephrine multiple interactions ISO RGD:11285 6480464 MAPK10 protein affects the reaction [MAPK9 protein affects the susceptibility to Phenylephrine] CTD PMID:16949803 phenylmercury acetate decreases expression ISO RGD:733441 6480464 Phenylmercuric Acetate results in decreased expression of MAPK10 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:733441 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAPK10 mRNA CTD PMID:27188386 potassium chloride multiple interactions ISO RGD:11285 6480464 MAPK10 protein affects the reaction [MAPK9 protein affects the susceptibility to Potassium Chloride] CTD PMID:16949803 potassium dichromate increases expression ISO RGD:11285 6480464 Potassium Dichromate results in increased expression of MAPK10 mRNA CTD PMID:23608068 quercetin multiple interactions ISO RGD:11285 6480464 Quercetin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK10 protein] CTD PMID:11543732 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAPK10 protein] CTD PMID:27389774 quinolin-8-ol increases expression ISO RGD:11285 6480464 Oxyquinoline results in increased expression of MAPK10 mRNA CTD PMID:15612046 reactive oxygen species multiple interactions ISO RGD:733441 6480464 [[Bortezomib co-treated with Butyrates] results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of and results in increased activity of MAPK10 protein, [[Bortezomib co-treated with vorinostat] results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of and results in increased activity of MAPK10 protein CTD PMID:15173093 rotenone increases response to substance ISO RGD:11285 6480464 MAPK10 results in increased susceptibility to Rotenone CTD PMID:20418776 rotenone multiple interactions ISO RGD:733441 6480464 [PSME4 protein affects the susceptibility to Rotenone] which results in decreased expression of MAPK10 mRNA CTD PMID:32368861 rotenone multiple interactions ISO RGD:11285 6480464 MAPK10 mutant form inhibits the reaction [Rotenone results in increased activity of CASP3 protein] CTD PMID:25496994 rotenone decreases response to substance ISO RGD:11285 6480464 MAPK10 gene mutant form results in decreased susceptibility to Rotenone CTD PMID:25496994 rotenone multiple interactions EXP 6480464 Curcumin analog inhibits the reaction [Rotenone results in increased phosphorylation of MAPK10 protein] CTD PMID:27535828 rotenone increases phosphorylation EXP 6480464 Rotenone results in increased phosphorylation of MAPK10 protein CTD PMID:27535828 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:733441 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MAPK10 mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:733441 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:733441 6480464 Silicon Dioxide analog results in decreased expression of MAPK10 mRNA, Silicon Dioxide results in decreased expression of MAPK10 mRNA CTD PMID:25351596 , PMID:25895662 sodium arsenite decreases activity ISO RGD:733441 6480464 sodium arsenite results in decreased activity of MAPK10 protein CTD PMID:23219847 sodium arsenite affects methylation ISO RGD:733441 6480464 sodium arsenite affects the methylation of MAPK10 gene CTD PMID:28589171 sodium arsenite increases phosphorylation EXP 6480464 sodium arsenite results in increased phosphorylation of MAPK10 protein CTD PMID:24952339 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of MAPK10 protein CTD PMID:11446828 , PMID:27966075 sodium arsenite multiple interactions EXP 6480464 Curcumin inhibits the reaction [sodium arsenite results in increased expression of MAPK10 protein], Curcumin inhibits the reaction [sodium arsenite results in increased phosphorylation of MAPK10 protein] CTD PMID:24952339 , PMID:27966075 sodium arsenite increases response to substance ISO RGD:11285 6480464 MAPK10 results in increased susceptibility to sodium arsenite CTD PMID:20418776 sodium arsenite decreases expression ISO RGD:733441 6480464 sodium arsenite results in decreased expression of MAPK10 mRNA, sodium arsenite results in decreased expression of MAPK10 protein modified form CTD PMID:23219847 , PMID:34032870 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of MAPK10 mRNA CTD PMID:11960910 streptozocin multiple interactions ISO RGD:11285 6480464 [Streptozocin co-treated with Dietary Fats] results in increased expression of MAPK10 mRNA, Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of MAPK10 mRNA] CTD PMID:33484791 sulfates affects methylation ISO RGD:733441 6480464 Sulfates affects the methylation of MAPK10 promoter CTD PMID:25395096 sulfates multiple interactions ISO RGD:733441 6480464 [Soot co-treated with Sulfates] affects the methylation of MAPK10 promoter CTD PMID:25395096 sulindac sulfide increases expression ISO RGD:733441 6480464 sulindac sulfide results in increased expression of MAPK10 mRNA CTD PMID:12734198 sunitinib decreases expression ISO RGD:733441 6480464 Sunitinib results in decreased expression of MAPK10 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:11285 6480464 Tamoxifen affects the expression of MAPK10 mRNA CTD PMID:17555576 titanium dioxide decreases expression ISO RGD:11285 6480464 titanium dioxide results in decreased expression of MAPK10 mRNA CTD PMID:23557971 titanium dioxide multiple interactions ISO RGD:11285 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MAPK10 mRNA CTD PMID:29950665 trichostatin A decreases expression ISO RGD:733441 6480464 trichostatin A results in decreased expression of MAPK10 mRNA CTD PMID:26272509 trichostatin A multiple interactions ISO RGD:733441 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAPK10 mRNA CTD PMID:27188386 valproic acid affects expression ISO RGD:733441 6480464 Valproic Acid affects the expression of MAPK10 mRNA CTD PMID:25979313 valproic acid increases methylation ISO RGD:733441 6480464 Valproic Acid results in increased methylation of MAPK10 gene CTD PMID:29501571 valproic acid decreases expression ISO RGD:733441 6480464 Valproic Acid results in decreased expression of MAPK10 mRNA CTD PMID:23179753 more ... vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of MAPK10 mRNA CTD PMID:19015723 vinclozolin affects expression ISO RGD:11285 6480464 vinclozolin affects the expression of MAPK10 mRNA CTD PMID:34182078 vorinostat multiple interactions ISO RGD:733441 6480464 [[Bortezomib co-treated with vorinostat] results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of and results in increased activity of MAPK10 protein more ... CTD PMID:15173093 zoledronic acid decreases expression ISO RGD:733441 6480464 zoledronic acid results in decreased expression of MAPK10 mRNA CTD PMID:24714768
